Amycretin: Is Novo Nordisk's Oral Wonder Drug the Future of Weight Loss and Diabetes Treatment?
The Great Rejection: Why Most Americans Are Turning Their Backs on New Weight-Loss Drugs
Beyond the Buzz: Unpacking the Perils of Cosmetic Weight-Loss Drugs